Results 291 to 300 of about 475,290 (309)

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly  

Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment

Ca-A Cancer Journal for Clinicians, 2017
Heather Greenlee, Melissa J Dupont-Reyes, Lynda G Balneaves   +2 more
exaly  

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

The role of the microbiome in cancer development and therapy

Ca-A Cancer Journal for Clinicians, 2017
Aadra P Bhatt, Matthew R Redinbo
exaly  

Radiotherapy combination opportunities leveraging immunity for the next oncology practice

Ca-A Cancer Journal for Clinicians, 2017
Fernanda G Herrera, Jean Bourhis, George Coukos   +2 more
exaly  

Physiologic effects of prothrombin depressant drugs and their clinical significance.

Chicago medicine, 1998
J L, KOPPEL, J H, OLWIN
openaire   +1 more source

Nanooncology: The future of cancer diagnosis and therapy

Ca-A Cancer Journal for Clinicians, 2013
Sanjiv S Gambhir
exaly  

[Chemical structure and physiologic effect of drugs].

Farmaceutski glasnik, 2004
openaire   +1 more source

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Ca-A Cancer Journal for Clinicians, 2015
Jeffrey S Wefel, Shelli R Kesler
exaly  

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

Ca-A Cancer Journal for Clinicians, 2016
Nader Sadeghi, Katherine A Hutcheson, Gary H Lyman   +2 more
exaly